Physician profile
Jeffrey E Rosen
NPI 1245226414
$37,263.02
in general payments reported to CMS, 2019-2025
20 companies · $2,163 in 2025
The $2,163 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,509 · 2020: $4,210 · 2021: $16K · 2022: $3,291 · 2023: $1,245 · 2024: $5,521 · 2025: $2,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,075 · Travel and Lodging: $2,695 · Consulting Fee: $2,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,074.53 |
| Travel and Lodging | $2,694.58 |
| Consulting Fee | $2,160.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharma Ag | $19,400.00 | 2020-2022 | |
| Stryker Corporation | $5,660.26 | 2019-2025 | Mako, Hoffmann, Pangea |
| Arthrex, INC. | $5,217.98 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $2,160.00 | 2024 | |
| Ferring Pharmaceuticals INC. | $1,428.28 | 2019-2023 | Euflexxa |
| Horizon Therapeutics Plc | $841.50 | 2019-2022 | |
| Suvon Surgical LLC | $706.31 | 2024-2025 | |
| Pacira Therapeutics, INC. | $594.86 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $389.20 | 2019-2023 | Iovera |
| Depuy Synthes Sales INC. | $345.12 | 2019-2024 | Orthovisc |
| Acumed LLC | $213.67 | 2024 | Acumed, Inframe Implant |
| Fidia Pharma USA INC. | $114.12 | 2019-2020 | |
| Orthofix Medical, INC. | $45.43 | 2019 | |
| Smith+Nephew, INC. | $35.83 | 2020 | |
| Convatec INC. | $32.52 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $24.07 | 2019 | |
| Anika Therapeutics, INC. | $15.81 | 2019 | |
| Axogen | $15.72 | 2019 | |
| Baudax Bio INC. | $11.53 | 2020 | |
| Gotham Surgical Solutions & Devices, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.